Taguchi Tomoko, Takenouchi Hisami, Shiozawa Yusuke, Matsui Jun, Kitamura Noriko, Miyagawa Yoshitaka, Katagiri Yoko U, Takahashi Takao, Okita Hajime, Fujimoto Junichiro, Kiyokawa Nobutaka
Department of Developmental Biology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan.
Exp Hematol. 2007 Sep;35(9):1398-407. doi: 10.1016/j.exphem.2007.05.019. Epub 2007 Jul 25.
The role of interleukin (IL)-7 in human B lymphopoiesis is still controversial. We used an in vitro culture system to verify involvement of IL-7 in development of human pro-B cells from hematopoietic stem cells.
Human CD34(+) bone marrow cells were cultured for 4 weeks on MS-5 mouse stromal cells to induce pro-B cells. Expression of IL-7 receptor alpha or other B-cell differentiation marker genes on cultured human CD34(+)bone marrow cells was investigated by reverse transcription polymerase chain reaction (RT-PCR). Colony assay of human CD34(+) bone marrow cells was also performed to determine the effect of IL-7 on colony-forming ability. Neutralizing antibody or reagent that eliminates the effect of IL-7 was added to the culture system, and the number of pro-B cells induced was estimated by flow cytometry.
RT-PCR analysis revealed mRNA expression of IL-7 receptor alpha as well as B-cell differentiation marker genes in not only CD19(+) pro-B cells but also CD19(-) CD33(-) cells induced from CD34(+) bone marrow cells after cultivation for 4 weeks on MS-5 cells. Addition of anti-mouse IL-7 antibody, anti-human IL-7 receptor alpha antibody, or JAK3 kinase inhibitor reduced the number of pro-B cells induced, demonstrating that elimination of IL-7 reduces pro-B-cell development. Addition of anti-mouse IL-7 antibody emphasized the colony-forming ability of burst-forming unit erythroid cells.
IL-7 produced by MS-5 cells is required for human pro-B-cell development from CD34(+)bone marrow cells in our culture system, and IL-7 appears to play a certain role in early human B lymphopoiesis.
白细胞介素(IL)-7在人类B淋巴细胞生成中的作用仍存在争议。我们使用体外培养系统来验证IL-7是否参与造血干细胞向人类前B细胞的发育过程。
将人类CD34(+)骨髓细胞在MS-5小鼠基质细胞上培养4周以诱导前B细胞。通过逆转录聚合酶链反应(RT-PCR)研究培养的人类CD34(+)骨髓细胞上IL-7受体α或其他B细胞分化标志物基因的表达。还进行了人类CD34(+)骨髓细胞的集落测定,以确定IL-7对集落形成能力的影响。向培养系统中添加中和抗体或消除IL-7作用的试剂,并通过流式细胞术估计诱导的前B细胞数量。
RT-PCR分析显示,在MS-5细胞上培养4周后,不仅CD19(+)前B细胞,而且从CD34(+)骨髓细胞诱导的CD19(-) CD33(-)细胞中均有IL-7受体α以及B细胞分化标志物基因的mRNA表达。添加抗小鼠IL-7抗体、抗人类IL-7受体α抗体或JAK3激酶抑制剂可减少诱导的前B细胞数量,表明消除IL-7会减少前B细胞的发育。添加抗小鼠IL-7抗体增强了红系爆式集落形成单位细胞的集落形成能力。
在我们的培养系统中,MS-5细胞产生的IL-7是CD34(+)骨髓细胞向人类前B细胞发育所必需的,并且IL-7似乎在人类早期B淋巴细胞生成中起一定作用。